These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 10090438

  • 1. The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers.
    Langley PC.
    Clin Ther; 1999 Jan; 21(1):236-53. PubMed ID: 10090438
    [Abstract] [Full Text] [Related]

  • 2. A cost-effectiveness analysis of breath-actuated metered-dose inhalers.
    Kelloway JS, Wyatt R.
    Manag Care Interface; 1997 Sep; 10(9):99-107. PubMed ID: 10175551
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of two beta 2-sympathicomimetics in different inhalers in children with asthma. Comparison of pirbuterol in a breath-actuated inhaler and salbutamol in a customary metered-dose inhaler.
    Völkl KP, Kroll VM, Wiesemann HG, Schneider B.
    Arzneimittelforschung; 1991 May; 41(5):533-6. PubMed ID: 1680327
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
    Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.
    Health Technol Assess; 2001 May; 5(26):1-149. PubMed ID: 11701099
    [Abstract] [Full Text] [Related]

  • 5. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 6. Could interchangeable use of dry powder inhalers affect patients?
    Price D, Summers M, Zanen P.
    Int J Clin Pract Suppl; 2005 Dec; (149):3-6. PubMed ID: 16279996
    [Abstract] [Full Text] [Related]

  • 7. Administration errors with a conventional metered dose inhaler versus a novel breath actuated device.
    Larsen JS, Hahn M, Kochevar JW, Morris RJ, Kaiser HB, Weisberg SC, Halverson PC, Quessy SN.
    Ann Allergy; 1993 Aug; 71(2):103-6. PubMed ID: 8346860
    [Abstract] [Full Text] [Related]

  • 8. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA, Riedel AA, Carranza Rosenzweig JR.
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [Abstract] [Full Text] [Related]

  • 9. Cost comparison of beta 2-agonist bronchodilators used in the treatment of asthma.
    Nightingale CH.
    Pharmacotherapy; 1995 Mar; 15(5):677-81. PubMed ID: 8570443
    [Abstract] [Full Text] [Related]

  • 10. Inhalatory therapy training: a priority challenge for the physician.
    Melani AS.
    Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
    [Abstract] [Full Text] [Related]

  • 11. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA.
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [Abstract] [Full Text] [Related]

  • 12. Cost effectiveness of asthma treatment with a breath-actuated inhaler: how has the story changed?
    Haycox A, Featherstone R.
    J Med Econ; 2008 Mar; 11(3):525-39. PubMed ID: 19450102
    [Abstract] [Full Text] [Related]

  • 13. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 14. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the Maxair Autohaler to wet nebulizer in patients with acute asthma.
    Silverman R, Sellers J, Greene S, Flaster E, Colice G.
    Chest; 1998 Sep; 114(3):766-70. PubMed ID: 9743164
    [Abstract] [Full Text] [Related]

  • 16. Assessing the cost of albuterol inhalers in the Michigan and California Medicaid Programs: a total cost-of-care approach.
    Tierce JC, Meller W, Berlow B, Gerth WC.
    Clin Ther; 1989 Sep; 11(1):53-61. PubMed ID: 2655905
    [Abstract] [Full Text] [Related]

  • 17. Loss of bronchodilator medication in priming a conventional metered dose inhaler: a cost of treating asthma.
    Ross RN.
    Med Interface; 1997 Apr; 10(4):141-6. PubMed ID: 10166801
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of efficacy of salbutamol via metered dose inhaler with volumatic spacer and via dry powder inhaler, easyhaler, to nebulization in mild to moderate severity acute asthma exacerbation in childhood.
    Vangveeravong M.
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S115-23. PubMed ID: 19253506
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.
    Rutten-van Mölken MP, van Doorslaer EK, Till MD.
    Pharmacoeconomics; 1998 Dec; 14(6):671-84. PubMed ID: 10346418
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of the everyday use of a metered dose aerosol triggered by inhalation (the "Autohaler" system)].
    Le Cocguic Y, Zureik M.
    Rev Pneumol Clin; 1997 Dec; 53(1):13-9. PubMed ID: 9181147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.